Next Article in Journal
Clinical Utility of Breast Ultrasound Images Synthesized by a Generative Adversarial Network
Next Article in Special Issue
Dental Treatment in Special Needs Patients and Uncooperative Young Children: A Retrospective Study
Previous Article in Journal
Mirizzi Syndrome—The Past, Present, and Future
Previous Article in Special Issue
Caries Lesion Assessment Using 3D Virtual Models by Examiners with Different Degrees of Clinical Experience
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 60
Issue 1
10.3390/medicina60010013
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Activity of Crataegi fructus Extract Used for Potential Application in the Prevention and Treatment of Oral Diseases

by
Seoul-Hee Nam
Department of Dental Hygiene, College of Health Science, Kangwon National University, Samcheok 25945, Gangwon-do, Republic of Korea
Medicina 2024, 60(1), 13; https://doi.org/10.3390/medicina60010013
Submission received: 10 November 2023 / Revised: 15 December 2023 / Accepted: 18 December 2023 / Published: 21 December 2023
(This article belongs to the Special Issue Medicine and Dentistry: New Methods and Clinical Approaches)
Browse Figures
Versions Notes

Abstract

:
Background and Objectives: This study evaluated the antimicrobial effect and cytotoxic potential of the natural Crataegi fructus extract against Streptococcus mutans (S. mutans), the causative agent of dental caries, which is a typical oral disease, and Candida albicans (C. albicans), which causes oral candidiasis. Materials and Methods: Crataegi fructus was shaken in 70% ethanol for 12 h to obtain samples through enrichment and lyophilization. Then, 1, 5, 10, 20, 30, and 40 mg/mL of the Crataegi fructus extract were applied to S. mutans and C. albicans to demonstrate its antimicrobial effect after 24 h. The stability of Crataegi fructus extract on the survival rate of human keratinocytes (HaCaT) was confirmed using water-soluble tetrazolium salt (WST-1) analysis. A one-way ANOVA determined the difference between each group. A Tukey HSD test was performed as a post-hoc analysis at the 0.05 significance level. Results: Crataegi fructus extract showed antimicrobial effects against S. mutans and C. albicans that increased in a concentration-dependent manner. However, high concentrations affected cell growth and lowered cell survival. The half maximal inhibitory concentration (IC50 value) of Crataegi fructus extract showed a survival rate of 53.04% at a concentration of 30 mg/mL, which was found to be applicable. Conclusions: Thus, Crataegi fructus extract may be used as a natural material for the prevention and treatment of oral diseases. Crataegi fructus demonstrates optimal antimicrobial effects without affecting cell proliferation and growth at 30 mg/mL concentration.

1. Introduction

Interest in oral health is gradually increasing due to reports associating oral health with improved quality of life [1]. It significantly promotes quality of life by enhancing confidence and satisfaction in social relations, as it affects not only the enjoyment of eating food, but also a person’s appearance and ability to communicate [2]. Although oral health care is important, in many cases it is neglected due to a lack of awareness of the connection between oral health and economic and social conditions [3]. Oral diseases caused by compromised oral health may lead to tooth loss; impaired masticatory function may cause a lack of nutritional intake; and pain and inflammation of the teeth and oral tissues may cause poor quality of meals, communication discomfort, and loss of confidence [4]. Moreover, reports show that people with poor oral health have poor general health [5]. Oral diseases and chronic systemic diseases have common risk factors and influence each other. Thus, they can be considered closely related [6].
Dental caries is a typical oral disease caused by bacteria, saliva, and food in dental plaque. Bacteria that cause dental caries include Streptococcus mutans (S. mutans) and S. sobrinus [7]. However, S. mutans is the main causative agent that adheres to tooth surfaces, and is found in large numbers in carious sites [8]. S. mutans resides in the oral cavity, adheres to tooth surfaces, helps secrete glucosyltransferase (GTFase), synthesizes glucan, enables bacterial adherence, and degrades sucrose. Organic acids produced by plaque bacteria lead to the dissolution of the hydroxyapatite of tooth enamel and damage the tooth surface, resulting in tooth loss [9]. Antimicrobial substances that target the causative bacterium, S. mutans, and inhibit its adhesion to tooth surfaces can help prevent dental caries [10].
Candida is detected even in most healthy people as an opportunistic pathogen. Candida species include Candida albicans (C. albicans), C. glabrata, C. krusei, C. parapisilosis, and C. tropicalis. Among them, C. albicans exhibits the highest toxicity levels and growth rates [11]. C. albicans is usually found as a commensal microorganism, and only when there is an imbalance in the organism C. albicans does it begin to act as an opportunistic pathogen. It can invade the oral tissues, such as the mucous membrane and tongue, reproduce in oral epithelial cells and dentures, causing adverse effects on oral health such as discomfort, burning pain, taste abnormalities, and dysphagia during chewing [12]. Oral candidiasis may heal spontaneously due to the recovery of immunity, but most cases require antibiotic therapy [13].
Antibiotics can inhibit bacterial growth in the oral cavity and minimize the risk of oral diseases such as dental caries and oral candidiasis [14]. However, chemicals pose potential risks and many side effects when used for prolonged periods. Thus, there is constant controversy over their safety [15]. Therefore, the growing need for new antimicrobial agents has led to research on alternative products, and natural compounds isolated from plants used in traditional medicine are proposed as good alternatives to synthetic chemicals [16]. Additionally, the World Health Organization (WHO) promotes the use of traditional herbal medicines due to their low toxicity, compounds, chemical composition, and the pharmacological potential of various plant species. In recent years, many studies have focused on natural extracts that can present safe alternative options for oral disease prevention, thus avoiding the side effects of chemical agents [17].
Several studies have evaluated natural extracts for oral diseases. One study showed that Momordica charantia extract inhibited S. mutans growth and reduced its adhesion on tooth surfaces, confirming its antimicrobial efficacy against S. mutans [18]. Another study demonstrated that Sambucus sieboldiana extract inhibited the growth of S. mutans, confirming its antimicrobial effect and anticariogenic potential [19]. Other studies have shown the antimicrobial effects of tea tree and peppermint essential oils on S. mutans [20]. Lespedeza cuneata extract [21] and Acanthopanax sessiliflorum extract [22] can inhibit the growth of C. albicans, which suggests their usefulness as antifungal substances for preventing oral diseases. Chamaecyparis obtuse extract has a high level of antioxidant and antifungal activity against C. albicans [23].
Crataegi fructus is the fruit of the Crataegus pinnatifida Bunge tree that belongs to the Rosaceae family. The tree grows naturally in Korea, China, and Japan. Its fruit has a peculiar aroma and a sweet and sour taste. It is used for edible and medicinal purposes [24]. Reports show that Crataegi fructus is an excellent natural material for the protection of the stomach, decomposition of fat cells, enhancement of memory, and improvement of hyperlipidemia, as well as having antidepressant, antioxidant, anti-inflammatory, anticancer, and antimicrobial effects [25]. The main chemical components of Crataegi fructus included crude protein, crude fat, ash, and carbohydrates. The highest free sugar content was fructose, followed by glucose, mannose, ribose, and galactose. Among 16 types of amino acids, glutamic acid content was the highest, and the main fatty acids were arachidic acid, oleic acid, linoleic acid, and palmitic acid. Among the organic acids, citric acid content was the highest, and it contained vitamin C; among the minerals, it contained the highest potassium (K) content, followed by calcium (Ca), magnesium (Mg), and Ferrum (Fe) [26]. Although studies on the antimicrobial efficacy of various natural extracts in oral diseases are ongoing, there is insufficient research on the antimicrobial effect of Crataegi fructus against oral microorganisms that cause oral diseases.
The epidermis acts as a barrier to protect the body from external substances, and HaCaT cells (human keratinocytes) that make up the oral epidermis are used as in vitro models to evaluate cytotoxicity [27,28,29]. Evaluating the cellular stability of promising plant extract oral antimicrobial agents is crucial for developing effective and safe agents. However, there are no studies on the cell stability of Crataegi fructus extracts to evaluate safe oral application.
Therefore, in this study, Crataegi fructus extract was applied to S. mutans, a typical bacterium that induces dental caries, to confirm its anti-caries effect, and C. albicans, the cause of oral candidiasis, to assess its antifungal effect. Moreover, the study evaluated the cytotoxicity of Crataegi fructus extract to confirm its usefulness for safe treatment or prevention of oral diseases.

2. Materials and Methods

2.1. Crataegi fructus Extract

The Crataegi fructus used in this study was grown in China and purchased from Cheongmyeong Co., Ltd. (Chungju, Gyeongsangbuk, Republic of Korea). Five times the amount of 70% ethanol was added to 100 g of pulverized Crataegi fructus and shaken at 60 °C for 24 h. The ratio of extract to solvent is 1:5. After filtering the extract three times using filter paper (Advantec No. 2, Tokyo, Japan), the supernatant that passed through the filter paper was concentrated using a rotary vacuum evaporative concentrator (N-1300E.V.S. EYELA Co., Tokyo, Japan). The concentrated extract was freeze-dried with a freeze dryer (FD5508, Ilshin Lab, Yangju, Kyunggi-do, Republic of Korea) to obtain the powder. The obtained powder was stored at −20 °C until use and diluted in dimethyl sulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO, USA).

2.2. Antimicrobial and Antifungal Activity

Strains of S. mutans (KCTC 3065/ATCC 25175) and C. albicans (KCTC 7965/ATCC 10231) were used after subculture in a brain-heart infusion broth (BHI broth, Sigma-Aldrich, St. Louis, MO, USA) and a yeast mold broth (YM broth, Difco, Foley, AL, USA), respectively, at 37 °C for 24 h. The colony-forming units (CFU)/mL were measured to determine the number of viable cells in the Crataegi fructus extract against S. mutans and C. albicans. After diluting the extract to concentrations of 1, 3, 5, 10, 20, 30, and 40 mg/mL in BHI broth and YM broth, 1 × 105 S. mutans and 1 × 104 C. albicans were mixed and subjected to culture at 37 °C for 24 h, then spread on a BHI agar medium and a YM agar medium, incubated for 24 h, and tested for CFU/mL.

2.3. Minimal Inhibitory Concentration (MIC) and Minimal Bactericidal Concentration (MBC) or Minimal Fungicidal Concentration (MFC) Measurements

The bacterial concentrations used in this measurement were about 1 × 105 S. mutans and 1 × 104 C. albicans CFU/mL, and the concentration gradients of Crataegi fructus extract were 1, 3, 5, 10, 20, 30, and 40 mg/mL. An inoculum suspension was incubated at 37 °C for 24 h. MIC and MBC or MFC values were determined by spreading different concentrations (1, 3, 5, 10, 20, 30, and 40 mg/mL) from each mixed tube onto the plate. MIC was set as the lowest concentration that inhibited the growth of a given strain of bacteria. The MBC or MFC was a concentration that kills 99.9% of bacteria and has been described as the lowest extract concentration at which no bacterial growth was observed. All tests were performed in triplicate.

2.4. Cytotoxic Effects

HaCaT cell lines (human keratinocytes) were grown in recommended culture media supplemented with Dulbecco’s Modified Eagle’s Medium (DMEM) (USA) containing 10% (v/v) heat-inactivated fetal bovine serum (FBS, Gibco, Grand Island, NY, USA) and 1% penicillin/streptomycin (100 μL/mL, Gibco, Grand Island, NY, USA) in a 5% CO2 humidified atmosphere at 37 °C. The cells were plated in a 96-well culture plate containing a final volume of 100 μL of medium. A suspension of 1  ×  105 cells/cm2 was seeded in 96-well plates and incubated at 37 °C for 24 h.
An evaluation of cytotoxicity was performed using water-soluble tetrazolium salt-1 (WST-1) analysis. The medium was changed to serum-free DMEM containing 1, 3, 5, 10, 20, 30, and 40 mg/mL concentrations of Crataegi fructus extract. After incubation for 3 h, the incubation medium was carefully aspirated, and the WST-1 solution was added to each well. The plates were incubated at 37 °C for 2 h, and the absorbance data were detected using a microplate reader (Multiskan FC, Thermo Fisher Scientific, Waltham, MA, USA) at 490 nm. Additionally, each test was replicated three times independently.

2.5. Statistical Analysis

Statistical analysis of the antimicrobial and antifungal effect was performed using IBM SPSS Statistics 24.0 (SPSS Inc., Chicago, IL, USA) to analyze the results of different concentrations of the Crataegi fructus extract at the 95% significance level, using one-way ANOVA. A Tukey HSD test was performed as a post-hoc test to confirm the differences according to the concentration of the extract.

3. Results

3.1. Changes in Oral Disease-Causing Bacteria and Yeast

The antimicrobial and antifungal effect against S. mutans and C. albicans was evident as the concentration of the Crataegi fructus extract increased (Figure 1). Growth inhibition confirmed a decrease in the CFU/mL with increased concentrations of Crataegi fructus extract, indicating a clear killing effect on S. mutans and C. albicans.
Table 1 presents statistical changes in CFU/mL. Statistically significant differences are shown between S. mutans and C. albicans treated with different concentrations of the Crataegi fructus extract (p < 0.05). The antimicrobial effect of Crataegi fructus extract added to the S. mutans increased with higher concentrations, although there was no statistically significant difference between the numbers of CFU/mL of S. mutans between groups when treated with 20 mg/mL and 40 mg/mL of the Crataegi fructus extract. As for C. albicans, there was also a significant difference between the number of CFU/mL with increasing concentration of Crataegi fructus extract. There was a clear decrease in CFU/mL depending on the application of Crataegi fructus extract, but there was no statistically significant difference from 3 mg/mL to 40 mg/mL (Table 1).

3.2. Determination of MIC and MBC or MFC

The MIC of Crataegi fructus extract was 30 mg/mL for S. mutans and 10 mg/mL for C. albicans. The MBC and MFC values showed that S. mutans was completely killed by 40 mg/mL, and C. albicans was completely killed by 20 mg/mL of extract application (Figure 2).

3.3. Cell Viability Assay Using HaCaT Cells

Cell viability was evaluated by a WST-1 assay for toxicity detection, as shown in Figure 3. Crataegi fructus extract significantly inhibited the viability of HaCaT cells in a concentration-dependent manner (p < 0.05). Treatment with Crataegi fructus extract induced a reduction in cell viability at approximately 99.44%, 98.65%, 97.72%, 92.23%, 75.17%, 53.04%, and 20.05% after applying 1, 3, 5, 10, 20, 30, and 40 mg/mL for 3 h. A 30 mg/mL concentration of the Crataegi fructus extract resulted in a 50% reduction of cell viability and half maximal inhibitory concentration (IC50 value).

4. Discussion

Health is the most fundamental right of all citizens, and is crucial to human life [30]. Oral care is essential, not only for maintaining healthy teeth and oral tissues, but also for improving physical health [31]. Moreover, since oral health is closely related to social relations and overall quality of life, oral health care is also important to improve quality of life [32]. Thus, tooth loss resulting from oral health problems can adversely affect general health and quality of life [33].
The oral cavity is an open ecosystem that receives a constant influx of microorganisms from the food we eat and the air we breathe, providing environmental conditions suitable for bacterial growth and reproduction. In general, the mucous membranes of the lips, palate, cheeks, tongue, gums, teeth, and saliva are densely populated by complex microbial communities, providing a favorable environment for the growth and reproduction of various microorganisms [34]. The bacterial flora is stable in a healthy state, but pathogenic flora resulting from an increase or decrease in the number of specific bacteria produce oral bacterial films, causing bad breath, dental caries, gingivitis, and periodontitis [35]. Poor oral hygiene, smoking or tobacco chewing, inadequate nutrition, and overuse of antibiotics can disrupt the homeostasis between the oral microbial communities and may even lead to antimicrobial resistance [36]. Therefore, infections and antibiotic resistance caused by oral diseases remain important health problems worldwide, causing serious diseases. To maintain healthier oral conditions, targeting and managing harmful oral disease-producing bacteria will help maintain good health and well-being.
Tooth brushing is the most basic and effective way to reduce oral bacteria. Furthermore, mechanical and chemical oral hygiene management methods can reduce oral bacterial load and improve overall oral health [37]. Currently, oral products such as toothpaste and chemical mouthwash agents are widely used to maintain oral health due to their strong antimicrobial effect. However, they cause problems and side effects, such as tooth discoloration, damage to the oral mucosa, and antibiotic resistance [38]. Moreover, reports show that the ethanol component of mouthwash may contribute to the development of oral cancer [39]. With reports on cell toxicity of various chemical agents, studies are focusing on pharmaceutically active natural extracts that are safe and devoid of side effects. These natural extracts are preferred due to their pharmacological efficacy and minimal side effects [40].
Crataegi fructus extract is used in Oriental medicine for promoting digestion and gastrointestinal function, improving blood circulation, and removing stagnant blood [41]. Crataegi fructus extract contains catechin (the main active ingredient), a flavonoid in many plants, exhibiting several pharmacological effects [42]. Therefore, in this study, Crataegi fructus extract, found to have anti-inflammatory and antimicrobial effects, was applied to S. mutans (a cariogenic bacterium) and C. albicans (causing oral candidiasis) to examine its antimicrobial effect on oral diseases.
The Crataegi fructus extract was added to each strain at concentrations of 1, 3, 5, 10, 20, 30, and 40 mg/mL, subjected to culture for 24 h, and tested for CFU/mL of the strains. The CFU/mL of S. mutans and C. albicans decreased with increasing concentrations of the Crataegi fructus extract. The inhibitory effect of S. mutans (4.58 ± 1.0 × 1012) growth according to the concentration of the Crataegi fructus extract was 2.37 ± 2.1 × 1012 at 1 mg/mL, 2.12 ± 1.6 × 1012 at 3 mg/mL, 1.75 ± 1.9 × 1012 at 5 mg/mL, 1.14 ± 1.7 × 1011 at 10 mg/mL, 6.79 ± 2.7 × 103 at 20 mg/mL, 1.60 ± 1.3 × 102 at 30 mg/mL, and 0.00 at 40 mg/mL. The inhibitory effect of C. albicans (4.75 ± 1.0 × 1012) growth was 2.59 ± 1.7 × 1010 at 1 mg/mL, 1.16 ± 1.9 × 103 at 3 mg/mL, 2.00 ± 2.1 × 101 at 5 mg/mL, 1.30 ± 1.4 × 101 at 10 mg/mL, and 0.00 at 20–40 mg/mL. These results indicate that higher concentrations of Crataegi fructus extract exhibited greater antimicrobial efficacy against oral disease-producing bacteria and yeast. Results showed that hawthorn fruit extract exhibited more effective antimicrobial activity against C. albicans than against S. mutans. In particular, C. albicans showed an antimicrobial and antifungal effect of 99.9% at a low concentration of 3 mg/mL of Crataegi fructus extract.
These results are similar to those of a study that first demonstrated the antimicrobial effect of citrus peel extract against S. mutans at a concentration of 5 mg/mL, which gradually increased as the concentration of the extract increased to 10 and 20 mg/mL [43]. Citrus sinensis peel extracts inhibited microbial growth at very high concentrations of 32 mg/mL against S. mutans [44]. In another study, following Solanum nigrum extract application to C. albicans at concentrations of 5, 10, 20, and 40 mg/mL, the number of CFU/mL of C. albicans decreased starting at 5 mg/mL and kept decreasing as the concentration of the extract increased [45]. The MIC of the Pechuel-Loeschea leubnitziae leaf extract for C. albicans was observed at 4.688 mg/mL, and the bacteriolytic effect was found at 37.5 mg/mL [46]. In this study, for S. mutans, the antimicrobial effect began to appear from 1 mg/mL, with no significant difference between 20 and 40 mg/mL, and the complete bacteria-killing effect was seen at 40 mg/mL. For C. albicans, the antimicrobial effect also began to appear from 1 mg/mL, but there was no distinct difference according to the concentration at 3 and 40 mg/mL, and the complete bacteria-killing effect was seen at 40 mg/mL. Crataegi fructus extract was more potent and effective against oral pathogens. Thus, the Crataegi fructus extract showed an antimicrobial effect against S. mutans and C. albicans starting from 1 mg/mL, but it exhibited a stronger antimicrobial effect against C. albicans, indicating stronger antifungal efficacy against oral candidiasis.
Herbal medicines may be considered safe because they are natural, but they can be toxic if not used correctly [47]. In vitro methods of cytotoxicity testing should quantify cell viability and growth [48]. Therefore, this study evaluated the effect of Crataegi fructus extract on cell proliferation of HaCaT cell lines. Cell growth began to decrease at a concentration of 20 mg/mL of Crataegi fructus extract; thus, 40 mg/mL of Crataegi fructus extract application was not safe for oral epidermal cells, and the IC50 value was 30 mg/mL. Crataegi fructus extract reduced HaCaT cell proliferation in a dose-dependent manner. Doses of 100 mg/mL of Desmodium adscendens extract are not safe and should be used with caution. Reports show that appropriate doses of 1 mg/mL and 10 mg/mL are safe and have a cytoprotective effect [49]. In this study, higher concentrations ranging from 1 mg/mL to 30 mg/mL were found to be appropriate and safe. These results demonstrated that up to 30 mg/mL of Crataegi fructus extract is safe for HaCaT cells and has excellent anti-caries and antifungal effects. Expanding the scope of applying functional natural materials is necessary for developing and using oral hygiene care products. Therefore, more research on natural substances is desirable to provide a promising source of natural products for improving oral health.
A limitation of this study is that we did not conduct analytical methodologies, including extraction, isolation, and characterization of active ingredients, which are critical for utilizing biologically active compounds from natural extracts for medicinal use. Crataegi fructus extract can be used in oral hygiene products with antimicrobial properties for minimizing the risk of dental caries and oral candidiasis. Additional studies are needed to isolate pure compounds associated with antimicrobial activity. Additionally, in vivo testing is needed to evaluate its toxicity and potential against oral pathogens. Crataegi fructus extract has antimicrobial efficacy, and human clinical studies are necessary to confirm changes in the oral environment following clinical application at safe concentrations.

5. Conclusions

Crataegi fructus extract, when applied to S. mutans and C. albicans for preventing and treating oral diseases, exhibited antimicrobial and antifungal efficacy that increased with increasing concentration. The study showed excellent antimicrobial effects when the Crataegi fructus extract was applied at a concentration of 40 mg/mL for S. mutans and 20 mg/mL for C. albicans. However, Crataegi fructus extract of up to 30 mg/mL was found to exhibit effective antimicrobial activity, and is believed to be an effective natural extract for the prevention and treatment of oral diseases at a concentration that does not affect cell growth or cause cytotoxicity.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Kim, Y.H.; Lee, J.H. The relationship of quality of health-related life with the status of oral health in adults. J. Korean Acad. Oral. Health 2016, 40, 165–170. [Google Scholar] [CrossRef]
  2. Carramolino-cuellar, E.; Tomas, I.; Jimenez-Soriano, Y. Relationship between the oral cavity and cardiovascular diseases and metabolic syndrome. Med. Oral. Patol. Oral. Cir. Bucal 2014, 19, e289–e294. [Google Scholar] [CrossRef] [PubMed]
  3. Jung, J.O. A study on the actual conditions of denture prosthodontics used by the elderly aged 65 or older in Seoul. J. Dent. Hyg. Sci. 2007, 7, 113–119. [Google Scholar]
  4. Albandar, J.M.; Brunelle, J.A.; Kingman, A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988–1994. J. Periodontol. 1999, 70, 13–29. [Google Scholar] [CrossRef]
  5. Richmond, S.; Chestnutt, I.; Shennan, J.; Brown, B. The relationship of medical and dental factors to perceived oral and general health. Community Dent. Epidemiol. 2007, 35, 89–97. [Google Scholar] [CrossRef] [PubMed]
  6. Kim, C.S.; Choi, Y.K. Survey of adults’ perceptions of the association between chronic diseases and oral health. J. Dent. Hyg. Sci. 2017, 17, 12–19. [Google Scholar] [CrossRef]
  7. Contardo, M.S.; Díaz, N.A.; Lobos, O.; Padilla, C.; Giacaman, R.A. Oral colonization by Streptococcus mutans and its association with the severity of periodontal disease in adults. Rev. Clín. Periodoncia Implantol. Rehabil. Oral. 2011, 4, 9–12. [Google Scholar] [CrossRef]
  8. Kim, H.K.; Park, H.W.; Shin, I.S.; Lee, J.H.; Seo, H.W. The antimicrobial effect of horseradish (Armoracia rusticana) root extracts against Streptococcus mutans isolated from human dental plaque. J. Korean Acad. Pediatr. Dent. 2008, 35, 225–234. [Google Scholar]
  9. Heo, N.S.; Choi, H.J.; Hwang, S.M.; Choi, Y.W.; Lee, Y.G.; Jo, W.H. Antimicrobial and anti-oral malodor efficacy of Schizandra chinensis extracts against oral pathogens. J. Life Sci. 2013, 23, 443–447. [Google Scholar] [CrossRef]
  10. Katsura, H.; Tsukiyama, R.I.; Suzuki, A.; Kobayashi, M. In vitro antimicrobial activities of bakuchiol against oral microorganisms. Antimicrob. Agents Chemother. 2001, 45, 3009–3013. [Google Scholar] [CrossRef]
  11. Bagg, J.; Macfarlane, T.W.; Poxtone, I.R.; Miller, C.H.; Smith, A.J. Essentials of Microbiology for Dental Students, 3rd ed.; Koonja Publishing: Seoul, Republic of Korea, 2008; pp. 154–196. [Google Scholar]
  12. Park, M.J.; Choi, Y.H.; Song, K.B.; Kim, E.K. Antifungal effects of hydrogen water on the growth of Candida albicans. J. Korean Acad. Oral. Health 2019, 43, 173–177. [Google Scholar] [CrossRef]
  13. Ellepola, A.N.; Samaranayake, L.P. Oral candida infections and antimycotics. Crit. Rev. Oral Biol. Med. 2000, 11, 172–198. [Google Scholar] [CrossRef] [PubMed]
  14. Almohefer, S.A.; Levon, J.A.; Gregory, R.L.; Eckert, G.J.; Lippert, F. Caries lesion remineralization with fluoride toothpastes and chlorhexidine—Effects of application timing and toothpaste surfactant. J. Appl. Oral Sci. 2018, 26, e20170499. [Google Scholar] [CrossRef] [PubMed]
  15. Fahimipour, A.K.; Ben Mamaar, S.; McFarland, A.G.; Blaustein, R.A.; Chen, J.; Glawe, A.J.; Kline, J.; Green, J.L.; Halden, R.U.; Wymelenberg, K.V.D.; et al. Antimicrobial chemicals associate with microbial function and antibiotic resistance indoors. mSystems 2018, 3, e00200-18. [Google Scholar] [CrossRef] [PubMed]
  16. Prabu, G.R.; Gnanamani, A.; Sadulla, S. Guaijaverin—A plant flavonoid as potential antiplaque agent against Streptococcus mutans. J. Appl. Microbiol. 2006, 101, 487–495. [Google Scholar] [CrossRef] [PubMed]
  17. Choi, J.Y.; Myung, H.J.; Chae, H.J. Screening of antibacterial essential oils from plant resources against oral bacteria. KSBB J. 2020, 35, 89–94. [Google Scholar] [CrossRef]
  18. Kim, D.W.; Lee, D.I.; Im, S.U.; Choi, Y.H.; Song, K.B. Effects of Diospyros kaki peel, Momordica charantia, and Canavalia gladiata extracts on the cariogenic traits of Streptococcus mutans. J. Korean Acad. Oral Health 2019, 43, 131–135. [Google Scholar] [CrossRef]
  19. Nam, S.H. Anticariogenic effect of Sambucuswilliamsii var. coreana NAKAI (S. Williamsii) extract on against Streptococcus mutans. Med. Legal Update 2020, 20, 2020–2024. [Google Scholar]
  20. Choi, Y.S.; Nam, S.H. Antibacterial activity of essential oils against Streptococcus mutans. Med. Legal Update 2020, 20, 1804–1809. [Google Scholar]
  21. Nam, S.H. The improvement effect of Lespedeza cuneata extract on oral health care. Ann. Rom. Soc. Cell Biol. 2021, 25, 1691–1699. [Google Scholar]
  22. Choi, Y.S.; Kim, N.H.; Kim, H.J.; An, S.J.; Lee, B.N.; Jung, M.J.; Hwang, J.Y.; Nam, S.H. A study on the antibacterial effect of Acanthopanax sessiliflorum on inflammatory diseases in the oral cavity. Biomed. Res. 2017, 28, 8376–8380. [Google Scholar]
  23. Kim, Y.; Kim, G.C.; Nam, S.H. Evaluation of antioxidant and antifungal activity of Chamaecyparis obtuse extract for use in oral herbal medicine. Appl. Sci. 2023, 13, 10236. [Google Scholar] [CrossRef]
  24. Park, S.J.; Shin, E.H.; Lee, J.H. Biological activities of solvent fractions from methanolic extract of Crataegi fructus. Korean J. Food Nutr. 2012, 25, 897–902. [Google Scholar] [CrossRef]
  25. Lee, J.J.; Lee, H.J. Comparisons of physicochemical composition of Korean and Chinese Crataegi fructrus. Korean J. Food Preserv. 2012, 19, 569–576. [Google Scholar] [CrossRef]
  26. Duan, Y.; Kim, M.A.; Seong, J.H.; Chung, H.S.; Kim, H.S. Antioxidative activities of various solvent extracts from haw (Crataegus pinnatifida Bunge). Korean J. Food Preserv. 2014, 21, 246–253. [Google Scholar] [CrossRef]
  27. Al-Tameemi, W.; Dunnill, C.; Hussain, O.; Komen, M.M.; van den Hurk, C.J.; Collett, A.; Georgopoulos, N.T. Use of in vitro human keratinocyte models to study the effect of cooling on chemotherapy drug-induced cytotoxicity. Toxicol. Vitr. 2014, 28, 1366–1376. [Google Scholar] [CrossRef]
  28. Hewitt, N.J.; Edwards, R.J.; Fritsche, E.; Goebel, C.; Aeby, P.; Scheel, J.; Reisinger, K.; Ouédraogo, G.; Duche, D.; Eilstein, J.; et al. Use of human in vitro skin models for accurate and ethical risk assessment: Metabolic considerations. Toxicol. Sci. 2013, 133, 209–217. [Google Scholar] [CrossRef]
  29. Odraska, P.; Mazurova, E.; Dolezalova, L.; Blaha, L. In vitro evaluation of the permeation of cytotoxic drugs through reconstructed human epidermis and oral epithelium. Klin. Onkol. 2011, 24, 195–202. [Google Scholar]
  30. Ahn, J.S.; Kim, H.J. A study on the determinants of children and adolescents’ health inequality in Korea. Stud. Korean Youth 2013, 24, 205–231. [Google Scholar]
  31. Migliorati, C.A.; Madrid, C. The interface between oral and systemic health: The need for more collaboration. Clin. Microbiol. Infect. 2007, 13, 11–16. [Google Scholar] [CrossRef]
  32. Boffano, P.; Roccia, F.; Pittoni, D.; Di Dio, D.; Forni, P.; Gallesio, C. Management of 112 hospitalized patients with spreading odontogenic infections: Correlation with DMFT and oral health impact profile 14 indexes. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2012, 113, 207–213. [Google Scholar] [CrossRef] [PubMed]
  33. Dahl, K.E.; Calogiuri, G.; Jönsson, B. Perceived oral health and its association with symptoms of psychological distress, oral status and socio-demographic characteristics among elderly in Norway. BMC Oral Health 2018, 18, 93. [Google Scholar] [CrossRef] [PubMed]
  34. Gao, L.; Xu, T.; Huang, G.; Jiang, S.; Gu, Y.; Chen, F. Oral microbiomes: More and more importance in oral cavity and whole body. Protein Cell 2018, 9, 488–500. [Google Scholar] [CrossRef] [PubMed]
  35. Paster, B.J.; Boches, S.K.; Galvin, J.; Ericson, R.E.; Lau, C.N.; Levanos, V.A.; Sahasrabudhe, A.; Dewhirst, F.E. Bacterial diversity in human subgingival plaque. J. Bacteriol. 2001, 183, 3770–3783. [Google Scholar] [CrossRef] [PubMed]
  36. Baker, J.L.; Edlund, A. Exploiting the oral microbiome to prevent tooth decay: Has evolution already provided the best tools? Front. Microbiol. 2018, 9, 3323. [Google Scholar] [CrossRef] [PubMed]
  37. Binney, A.; Addy, M.; Newcombe, R.G. The effect of a number of commercial mouthrinses compared with toothpaste on plaque regrowth. J. Periodontol. 1992, 63, 839–842. [Google Scholar] [CrossRef]
  38. Park, J.H.; Song, K.Y. Comparison of oral care interventions on the oral status of intubated patients in intensive care units. J. Korean Acad. Nurs. 2010, 17, 324–333. [Google Scholar]
  39. McCullough, M.J.; Farah, C.S. The role of alcohol in oral carcinogenesis with particular reference to alcohol containing mouth washes. Aust. Dent. J. 2008, 53, 302–305. [Google Scholar] [CrossRef]
  40. Aruoma, O.I.; Spencer, J.P.E.; Rossi, R.; Aeschbach, R.; Khan, A.; Mahmood, N.; Munoz, A.; Murcia, A.; Butler, J.; Halliwell, B. An evaluation of the antioxidant and antiviralaction of extracts of rosemary and provencal herbs. Food Chem. Toxicol. 1996, 34, 449–456. [Google Scholar] [CrossRef]
  41. Chang, Q.; Zuo, Y.; Harrison, F.; Chow, M.S. Hawthorn—An overview of chemical, pharmacological and clinical studies. J. Clin. Pharmacol. 2002, 42, 605–612. [Google Scholar] [CrossRef]
  42. Tadić, V.M.; Dobrić, S.; Marković, G.M.; Dordević, S.M.; Arsić, I.A.; Menković, N.R.; Stević, T. Anti -inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. J. Agric. Food Chem. 2008, 56, 7700–7709. [Google Scholar] [CrossRef] [PubMed]
  43. Choi, B.R.; Kang, J.; Kang, K.H. Antibacterial effects of extracts from citrus peels. J. Dight. Converg. 2012, 10, 559–564. [Google Scholar]
  44. Shetty, S.B.; Mahin-Syed-Ismail, P.; Varghese, S.; Thomas-George, B.; Kandathil-Thajuraj, P.; Baby, D.; Haleem, S.; Sreedhar, S.; Devang-Divakar, D. Antimicrobial effects of Citrus sinensis peel extracts against dental caries bacteria: An in vitro study. J. Clin. Exp. Dent. 2016, 8, e71–e77. [Google Scholar] [CrossRef] [PubMed]
  45. Choi, Y.R.; Kang, M.K. A convergence study of antibacterial effect of Solanum nigrum extract on Candida albicans. J. Korea Converg. Soc. 2018, 9, 69–74. [Google Scholar]
  46. Muhongo, M.N.; Kangogo, M.; Bii, C. The antimicrobial activity of Pechuel-Loeschea leubnitziae leaf extract and its effect on the expression level of methicillin resistant Staphylococcus aureus and Candida albicans virulence-associated genes. bioRxiv 2022. [Google Scholar] [CrossRef]
  47. Maixent, J.M. Opinion paper food supplements: The European regulation and its application in France. Thoughts on safety of food supplements. Cell Mol. Biol. 2012, 58, OL1720-9. [Google Scholar]
  48. ISO 10993-5; Biological Evaluation of Medical Devices. Part 5: Tests for Cytotoxicity: In Vitro Methods. ISO: Geneva, Switzerland, 1992.
  49. François, C.; Fares, M.; Baiocchi, C.; Maixent, J.M. Safety of Desmodium adscendens extract on hepatocytes and renal cells. Protective effect against oxidative stress. J. Intercult. Ethnopharmacol. 2015, 4, 1–5. [Google Scholar] [CrossRef]
Medicina 60 00013 g001
Figure 1. Antimicrobial effect of Crataegi fructus extract on S. mutans and C. albicans.
Figure 1. Antimicrobial effect of Crataegi fructus extract on S. mutans and C. albicans.
Medicina 60 00013 g001
Medicina 60 00013 g002
Figure 2. The MIC and MBC or MFC against (a) S. mutans and (b) C. albicans using Crataegi fructus extract after 24 h.
Figure 2. The MIC and MBC or MFC against (a) S. mutans and (b) C. albicans using Crataegi fructus extract after 24 h.
Medicina 60 00013 g002
Medicina 60 00013 g003
Figure 3. The cytotoxicity elicited by Crataegi fructus extract on HaCaT cells after 3 h of treatment. * Different letters (a, b, c, and d) indicate statistically significant results of the one-way ANOVA and post-hoc Tukey HSD (p < 0.05).
Figure 3. The cytotoxicity elicited by Crataegi fructus extract on HaCaT cells after 3 h of treatment. * Different letters (a, b, c, and d) indicate statistically significant results of the one-way ANOVA and post-hoc Tukey HSD (p < 0.05).
Medicina 60 00013 g003
Table 1. Comparison of CFU/mL and different concentrations of Crataegi fructus extract. Unit: Mean ± S.D.
Table 1. Comparison of CFU/mL and different concentrations of Crataegi fructus extract. Unit: Mean ± S.D.
Group0 mg/mL1 mg/mL3 mg/mL5 mg/mL10 mg/mL20 mg/mL30 mg/mL40 mg/mLANOVA
p-Value
S. mutans4.58 ± 1.0
1012,a		2.37 ± 2.1
1012,b		2.12 ± 1.6
1012,b		1.75 ± 1.9
1012,c		1.14 ± 1.7
1011,d		6.79 ± 2.7
103,e		1.60 ± 1.3
102,e		0.00 e0.000 *
C. albicans4.75 ± 1.0
1012,a		2.59 ± 1.7
1010,b		1.16 ± 1.9
103,c		2.00 ± 2.1
101,c		1.30 ± 1.4
101,c		0.00 c0.00 c0.00 c0.000 *
* Different letters (a, b, c, d, and e) indicate statistically significant results of the one-way ANOVA and post-hoc Tukey HSD (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nam, S.-H. Antimicrobial Activity of Crataegi fructus Extract Used for Potential Application in the Prevention and Treatment of Oral Diseases. Medicina 2024, 60, 13. https://doi.org/10.3390/medicina60010013

AMA Style

Nam S-H. Antimicrobial Activity of Crataegi fructus Extract Used for Potential Application in the Prevention and Treatment of Oral Diseases. Medicina. 2024; 60(1):13. https://doi.org/10.3390/medicina60010013

Chicago/Turabian Style

Nam, Seoul-Hee. 2024. "Antimicrobial Activity of Crataegi fructus Extract Used for Potential Application in the Prevention and Treatment of Oral Diseases" Medicina 60, no. 1: 13. https://doi.org/10.3390/medicina60010013

APA Style

Nam, S.-H. (2024). Antimicrobial Activity of Crataegi fructus Extract Used for Potential Application in the Prevention and Treatment of Oral Diseases. Medicina, 60(1), 13. https://doi.org/10.3390/medicina60010013

Article Metrics

Back to TopTop